Annual Report 2012
Annual Report 2012
Annual Report 2012
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
The <strong>2012</strong> Heraeus Innovation Award and other indicators<br />
highlighted the success of research and development<br />
activities: The Chemicals Division successfully introduced<br />
an innovative process for largescale technical manufacture<br />
of the preliminary catalyst platinum oxalate. In<br />
addition, a process innovation in China enabled the processing<br />
of fluorinated materials in a new recycling plant<br />
for precious metals. The Medical Components Division<br />
developed a magnetically hard, preciousmetal alloy for<br />
implants for treating patients with advanced cardiac<br />
failure. In addition, the division opened a development<br />
center for materials used in medical technology.<br />
Total expenditures for research and development amounted<br />
to € 24.0 million in <strong>2012</strong> (previous year: €17.8 million).<br />
The division achieved an innovation rate of 29.5%,<br />
which was below the previous year’s record level.<br />
41